drugset / Trial / NCT02534610

Analgesic Benefit of Preoperative vs. Postoperative Etoricoxib in Total Knee Arthroplasty

NCT02534610

Completed 165 enrolled Foisor Orthopedics Clinical Hospital
RandomizedCrossoverTriple-blindPrevention

Summary

Evaluation of the efficacy of preemptive versus postoperative administration of etoricoxib in total knee arthroplasty (TKA).

Timeline

Start
2014-01
Primary completion
2014-08
Completion
2014-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Etoricoxib Small molecule 120 mg Oral

Indications

No indication recorded.